ClearPoint Neuro
CLPT
60 hedge funds and large institutions have $42M invested in ClearPoint Neuro in 2023 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 20 increasing their positions, 12 reducing their positions, and 18 closing their positions.
169% more call options, than puts
Call options by funds: $549K | Put options by funds: $204K
67% more repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 12
10% more capital invested
Capital invested by funds: $38.3M → $42M (+$3.72M)
4.95% more ownership
Funds ownership: 18.68% → 23.63% (+5%)
2% more funds holding
Funds holding: 59 → 60 (+1)
6% more first-time investments, than exits
New positions opened: 19 | Existing positions closed: 18
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$8.19M |
| 2 |
State Street
Boston,
Massachusetts
|
+$2.03M |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$1.75M |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$1.32M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.07M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$1.7M |
| 2 |
EIM
Essex Investment Management
Boston,
Massachusetts
|
-$1.66M |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$1.06M |
| 4 |
Jane Street
New York
|
-$874K |
| 5 |
Goldman Sachs
New York
|
-$868K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
76
Point72 Asset Management
Stamford,
Connecticut
| – | -$20.4K | -2,422 | Closed |
|
|
ASN
77
Advisory Services Network
Atlanta,
Georgia
| – | -$7.6K | -900 | Closed |
|
|
PVH
78
Psagot Value Holdings
Tel Aviv,
Israel
| – | -$3K | -380 | Closed |
|
CLPT Hedge Fund Activity: Q2 2023 in Review
60 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in ClearPoint Neuro (CLPT) for Q2 2023, worth a combined $42M — up 9.7% from $38.3M a quarter earlier.
Buyers outnumbered sellers: 19 funds opened new CLPT positions and 18 closed out — a net gain of 1 holder — while 20 added to existing stakes and 12 trimmed.
The largest buyer was BlackRock, adding an estimated $8.19M. The largest seller was Millennium Management, cutting an estimated $1.7M.
- 60 institutional investors held ClearPoint Neuro (CLPT) as of Q2 2023, up from 59 in Q1 2023.
- Funds reported $42M of ClearPoint Neuro stock for Q2 2023, up 9.7% quarter-over-quarter.
- 19 funds opened new ClearPoint Neuro positions in Q2 2023 and 18 closed out, a net change of +1 holder.
- The largest ClearPoint Neuro buyer in Q2 2023 was BlackRock, an estimated $8.19M added.
- The largest ClearPoint Neuro seller in Q2 2023 was Millennium Management, an estimated $1.7M sold.
Based on aggregated 13F filings for Q2 2023.